Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production

[cafead]

via Manufacturing investments have taken center stage in recent years — from some pharma giants ramping up GLP-1 manufacturing capacity to meet soaring demand to other companies focusing on advanced capabilities that could ensure an adequate supply of vaccines.

article source